염증성 관절염 마우스 모델에서 Sauchinone의 치료 효과 = The Therapeutic Effect of Sauchinone on Inflammatory Arthritis in Mice

다국어 초록 (Multilingual Abstract)

Objective. Rheumatoid arthritis (RA) is a chronic inflammatory disease, mainly involving joints and bones. Sauchinone is an anti-inflammatory agent isolated from Saururus chinensis, which was used in oriental medicine. The aim of this study was to evaluate the therapeutic effect of sauchinone on inflammatory arthritis and underlying mechanism of anti-arthritic effect. Methods. Mice with collagen induced arthritis (CIA) was intraperitoneally injected with sauchinone (20 mg/kg) or vehicle. The clinical and histological evaluations were performed with arthritis scoring and hematoxylin-eosin staining, respectively. CD4+ interleukin (IL) 17+ T cells were determined under Th17 skewing condition treated with sauchinone. To evaluate the effect of sauchinone on osteoclastogenesis, mice bone marrow macrophages (BMMs) and human peripheral blood mononuclear cells (PBMCs) were cultured with macrophage-colony stimulating factor and receptor activator of nuclear factor-κB ligand in the absence or presence of sauchinone. Results. Sauchinone significantly attenuated the inflammatory arthritis in CIA mice both clinically and histologically. The proportion of Th17 cells were decreased with treatment with sauchinone in vivo and in vitro. The expressions of Th17 cell markers (IL-17 and retinoic acid receptor-related orphan receptor gamma t) and B cell markers (activation-induced cytidine deaminase) were downregulated in the presence of sauchinone. Sauchinone also suppressed the formation of tartrate-resistant acid phosphatase positive cells from mice BMMs and human PBMCs, and the expression of osteoclastogenic markers. Conclusion. Sauchinone alleviates inflammatory arthritis in mice through inhibition of Th17 differentiation and osteoclastogenesis. Sauchinone, one of traditional herbal medicine, could be a therapeutic candidate for the treatment of RA. (J Rheum Dis 2016;23:161-173)

참고문헌 (Reference)

1 Scott DL, "Tumor necrosis factor inhibitors for rheumatoid arthritis" 355 : 704-712, 2006

2 Bax M, "The pathogenic potential of autoreactive antibodies in rheumatoid arthritis" 36 : 313-325, 2014

3 McInnes IB, "The pathogenesis of rheumatoid arthritis" 365 : 2205-2219, 2011

4 Yang XO, "T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR alpha and ROR gamma" 28 : 29-39, 2008

5 Bae HB, "Sauchinone, a lignan from Saururus chinensis, reduces tumor necrosis factor-alpha production through the inhibition of c-raf/MEK1/2/ERK 1/2 pathway activation" 10 : 1022-1028, 2010

6 Han HJ, "Sauchinone, a lignan from Saururus chinensis, attenuates neutrophil pro-inflammatory activity and acute lung injury" 17 : 471-477, 2013

7 Li B, "Sauchinone suppresses pro-inflammatory mediators by inducing heme oxygenase-1 in RAW264.7 macrophages" 34 : 1566-1571, 2011

8 Jang EY, "Sauchinone suppresses lipopolysaccharide-induced inflammatory responses through Akt signaling in BV2 cells" 14 : 188-194, 2012

9 Jeong GS, "Sauchinone protects pancreatic β cells against cytokine-mediated toxicity" 25 : 505-512, 2011

10 Yang XO, "STAT3 regulates cytokine-mediated generation of inflammatory helper T cells" 282 : 9358-9363, 2007

11 Seo CS, "Protective effect of lignans against sepsis from the roots of Saururus chinensis" 31 : 523-526, 2008

12 Kay HY, "Nrf2-mediated liver protection by sauchinone, an antioxidant lignan, from acetaminophen toxicity through the PKCδ-GSK3β pathway" 163 : 1653-1665, 2011

13 Miossec P, "Interleukin-17 and type 17helper T cells" 361 : 888-898, 2009

14 Zhang F, "Interactions among the transcription factors Runx1, RORgammat and Foxp3 regulate the differentiation of interleukin 17-producing T cells" 9 : 1297-1306, 2008

15 Song SY, "Inhibitory effect of ent-Sauchinone on amyloidogenesis via inhibition of STAT3-mediated NF-κB activation in cultured astrocytes and microglial BV-2 cells" 11 : 118-, 2014

16 Lee AK, "Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-alpha and COX-2 expression by sauchinone effects on I-kappaBalpha phosphorylation, C/EBP and AP-1 activation" 139 : 11-20, 2003

17 Lee CS, "Inhibition of double-stranded RNA-induced inducible nitric oxide synthase expression by fraxinellone and sauchinone in murine microglia" 32 : 1870-1874, 2009

18 Kim YW, "Inhibition of SREBP-1c-mediated hepatic steatosis and oxidative stress by sauchinone, an AMPK-activating lignan in Saururus chinensis" 48 : 567-578, 2010

19 Kim YW, "Efficacy of sauchinone as a novel AMPK-activating lignan for preventing iron-induced oxidative stress and liver injury" 47 : 1082-1092, 2009

20 Smolen JS, "EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update" 73 : 492-509, 2014

21 Camps M, "Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis" 11 : 936-943, 2005

22 Nakken B, "B-cells and their targeting in rheumatoid arthritis--current concepts and future perspectives" 11 : 28-34, 2011

23 Singh JA, "2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis" 64 : 625-639, 2012